What changed in Medline Inc.'s latest annual report
In the year ended 31 Dec 2025, Medline Inc.'s revenue rose 11.5% to USD 28.43bn, from USD 25.51bn; cash and cash equivalents rose 874.4% to USD 1.94bn, from USD 199.00m; long-term debt fell 24% to USD 12.48bn, from USD 16.42bn.
Year ended 31 Dec 2025. Source: 10-K filed 25 Feb 2026, read it on SEC EDGAR.
USD 25.51bn to USD 28.43bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 25.51bn | 28.43bn | Up 11.5% |
| Net income | Not reported | 1.16bn | Not comparable |
| Total assets | 35.98bn | 38.48bn | Up 7% |
| Total liabilities | 19.45bn | 19.20bn | Down 1.3% |
| Long-term debt | 16.42bn | 12.48bn | Down 24% |
| Cash and cash equivalents | 199.00m | 1.94bn | Up 874.4% |
| Shareholders' equity | Not reported | 10.74bn | Not comparable |
Questions people ask
Did Medline Inc.'s revenue grow last year?
Revenue grew 11.5%, from USD 25.51bn to USD 28.43bn in the year ended 31 Dec 2025.
Is Medline Inc. profitable?
Yes. Net income was USD 1.16bn in the year ended 31 Dec 2025.
How much cash and debt does Medline Inc. have?
At its latest year end (31 Dec 2025), Medline Inc. reported cash and cash equivalents of USD 1.94bn and long-term debt of USD 12.48bn.
Where do these numbers come from?
From Medline Inc.'s own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Medline Inc.?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Surgical & Medical Instruments & Apparatus companies
- Stryker CorpLong-term debt up 21.9%
- 3M CompanyShareholders' equity up 22.4%
- Boston Scientific CorporationCash and cash equivalents up 374.6%
- Becton, Dickinson And CompanyCash and cash equivalents down 62.7%
- ResMed Inc.Long-term debt down 39.3%
- Dexcom, Inc.Cash and cash equivalents up 51.4%
- West Pharmaceutical Services, Inc.Cash and cash equivalents up 63.3%
- Solventum CorporationNet income up 224.8%